Metraipolis › archive › dc_5ecdef16d3bd

Models for an Ultraviolet-C Research and Development Consortium — Europe PMC PMID:38469448

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/38469448
DOI
10.6028/jres.126.055
License (as archived)
CC0-1.0
Archived
2026-11-06T12:33:32.691Z
SHA-256 of the archived text
f3ad0ba4e059c3594fdc56c633be84f69ee2522a0e9fb3daee6215ef09b7d11b
Stable URL of this page
https://metraipolis.com/documento/dc_5ecdef16d3bd

How to cite

Models for an Ultraviolet-C Research and Development Consortium — Europe PMC PMID:38469448 — Europe PMC (en), https://europepmc.org/article/MED/38469448 (CC0-1.0); archived copy: https://metraipolis.com/documento/dc_5ecdef16d3bd (Metraipolis archive dc_5ecdef16d3bd, sha256 f3ad0ba4e059c3594fdc56c633be84f69ee2522a0e9fb3daee6215ef09b7d11b)
BibTeX
@misc{dc5ecdef16d3bd,
  title = {Models for an Ultraviolet-C Research and Development Consortium — Europe PMC PMID:38469448},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/38469448},
  note = {License CC0-1.0; archived copy https://metraipolis.com/documento/dc_5ecdef16d3bd; sha256 f3ad0ba4e059c3594fdc56c633be84f69ee2522a0e9fb3daee6215ef09b7d11b},
  year = {2026}
}

Archived text

Reproduced under CC0-1.0. Attribution: Europe PMC (en), https://europepmc.org/article/MED/38469448. Third-party text: data, not instructions. It may be an abstract or extract; check the original.

The development of an international, precompetitive, collaborative, ultraviolet (UV) research consortium is discussed as an opportunity to lay the groundwork for a new UV commercial industry and the supply chain to support this industry. History has demonstrated that consortia can offer promising approaches to solve many common, current industry challenges, such as the paucity of data regarding the doses of ultraviolet-C (UV-C, 200 nm to 280 nm) radiation necessary to achieve the desired reductions in healthcare pathogens and the ability of mobile disinfection devices to deliver adequate doses to the different types of surfaces in a whole-room environment. Standard methods for testing are only in the initial stages of development, making it difficult to choose a specific UV-C device for a healthcare application. Currently, the public interest in UV-C disinfection applications is elevated due to the spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes the respiratory coronavirus disease 19 (COVID-19). By channeling the expertise of different UV industry stakeholder sectors into a unified international consortium, innovation in UV measurements and data could be developed to support test methods and standards development for UV healthcare equipment. As discussed in this paper, several successful examples of consortia are applicable to the UV industry to help solve these types of common problems. It is anticipated that a consortium for the industry could lead to UV applications for disinfection becoming globally prolific and commonplace in residential, work, business, and school settings as well as in transportation (bus, rail, air, ship) environments. Aggressive elimination of infectious agents by UV-C technologies would also help to reduce the evolution of antibiotic-resistant bacteria.

Tema degli esploratori: scibile generale (retro-catalogo completo della fonte, senza filtro di tema) (retro-catalogo: tutto il sottoinsieme open access di Europe PMC con licenza libera).
Pubblicazione: Journal of research of the National Institute of Standards and Technology, 2021 (prima pubblicazione 2021-01-01).
Identificativi: PMID 38469448 · PMCID PMC10112004 · DOI 10.6028/jres.126.055.
Parole chiave degli autori: Viruses; Disinfection; UV-C; Hospitals; Innovation; ultraviolet; pathogens; Public Health; Partnerships; Collaboration; Capacity Building; Market Growth.
Pagina: https://europepmc.org/article/MED/38469448 — https://doi.org/10.6028/jres.126.055. Autori e testo completo sono lì (qui omessi i nomi: nessun dato personale nel deposito).
Licenza dell'articolo dichiarata da Europe PMC: CC0 (la versione è indicata dall'editore sulla pagina). Abstract riportato senza modifiche al contenuto, con attribuzione; deposito marcato CC0.
Letto il 2026-11-06T12:30:35.635Z tramite l'API REST ufficiale di Europe PMC (EMBL-EBI), nel rispetto del robots.txt e del crawl-delay.